antipsychotic

Lyndra Therapeutics, layoff, schizophrenia, LYN-005, Gilead Sciences, antipsychotic,

Lyndra Therapeutics slashes staff and moves HQ ahead of pivotal data for weekly oral schizophrenia pill

Anika Sharma

Lyndra Therapeutics is undergoing significant changes, including the appointment of Jessica Ballinger as its new CEO, following the replacement of ...